Orviva

Learn · Variants · VKORC1

rs61742245 VKORC1

Genotype AC is associated with increased dose of warfarin in people with warfarin maintenance treatment as compared to genotype CC.

Imported from PharmGKB · not individually reviewed Drug response · dbSNP

What is rs61742245?

rs61742245 is a single-nucleotide polymorphism (SNP) in the VKORC1 gene (Vitamin K epoxide reductase complex subunit 1). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as AC. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs61742245 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
ACtypicalGenotype AC is associated with increased dose of warfarin in people with warfarin maintenance treatment as compared to genotype CC.80%
AtypicalAllele A is associated with increased dose of warfarin as compared to allele C.80%

Which drugs have annotations for rs61742245?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
Genotype AC is associated with increased dose of warfarin in people with warfarin maintenance treatment as compared to genotype CC., Allele A is associated with increased dose of warfarin as compared to allele C.

Is rs61742245 on 23andMe and AncestryDNA chips?

Chip coverage is not recorded for this variant. Orviva reports it when a raw-data file contains it directly or via a well-correlated proxy SNP, and says so when it does not.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.